Articles

Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex-vivo treated pediatric T-cell acute lymphoblastic leukemia cells

Childhood Leukaemia Investigation Prague, Czech Republic; Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague, Czech Republic
Fondazione Tettamanti, Clinica Pediatrica Università degli Studi Milano Bicocca, Monza (MB), Italy
Childhood Leukaemia Investigation Prague, Czech Republic; Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague, Czech Republic
German Rheumatism Research Center Berlin (DRFZ), a Leibniz Institute, Berlin, Germany
German Rheumatism Research Center Berlin (DRFZ), a Leibniz Institute, Berlin, Germany
Pediatric Hematology, Oncology and Stem Cell Transplant Division, Women and Child Health Department, University of Padova, Padova, Italy
Pediatric Hematology, Oncology and Stem Cell Transplant Division, Women and Child Health Department, University of Padova, Padova, Italy
Fondazione Tettamanti, Clinica Pediatrica Università degli Studi Milano Bicocca, Monza (MB), Italy
Childhood Leukaemia Investigation Prague, Czech Republic; Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague, Czech Republic
Fondazione Tettamanti, Clinica Pediatrica Università degli Studi Milano Bicocca, Monza (MB), Italy
Haematologica Early view Oct 21, 2021 https://doi.org/10.3324/haematol.2021.278796